Omkar Pharmachem Limited (BOM:532167)
India
· Delayed Price · Currency is INR 28.03
0.00 (0.00%)
At close: Apr 27, 2026
Omkar Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 5.1 | 5.4 | 5.4 | 5.4 | 5.4 | 2.7 | Upgrade
|
| Revenue Growth (YoY) | -5.56% | - | - | - | 100.00% | 500.00% | Upgrade
|
| Cost of Revenue | 2.04 | 1.61 | 1.61 | 1.39 | 1.75 | 1.51 | Upgrade
|
| Gross Profit | 3.06 | 3.79 | 3.8 | 4.01 | 3.65 | 1.19 | Upgrade
|
| Selling, General & Admin | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | Upgrade
|
| Other Operating Expenses | 0.89 | 0.83 | 0.9 | 0.84 | 0.9 | 0.91 | Upgrade
|
| Operating Expenses | 1 | 0.94 | 1.01 | 0.93 | 0.98 | 0.99 | Upgrade
|
| Operating Income | 2.06 | 2.85 | 2.78 | 3.08 | 2.67 | 0.21 | Upgrade
|
| Interest Expense | -0.19 | -0.17 | -0.29 | -0.47 | -0.56 | -0.57 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.02 | 0.04 | 0.03 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.02 | - | - | - | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | 1.91 | 2.7 | 2.53 | 2.65 | 2.11 | -0.36 | Upgrade
|
| Pretax Income | 1.91 | 2.7 | 2.53 | 2.65 | 2.11 | -0.36 | Upgrade
|
| Income Tax Expense | 1.06 | 0.69 | 0.64 | 0.67 | 0.27 | -2.57 | Upgrade
|
| Net Income | 0.85 | 2.01 | 1.89 | 1.98 | 1.83 | 2.21 | Upgrade
|
| Net Income to Common | 0.85 | 2.01 | 1.89 | 1.98 | 1.83 | 2.21 | Upgrade
|
| Net Income Growth | -58.69% | 6.24% | -4.40% | 8.03% | -17.30% | - | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | -0.03% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.08 | 0.20 | 0.19 | 0.20 | 0.18 | 0.22 | Upgrade
|
| EPS (Diluted) | 0.08 | 0.20 | 0.19 | 0.20 | 0.18 | 0.22 | Upgrade
|
| EPS Growth | -58.68% | 6.24% | -4.40% | 8.97% | -18.02% | - | Upgrade
|
| Free Cash Flow | - | 2.4 | 2.86 | 2.76 | 1.96 | 0.22 | Upgrade
|
| Free Cash Flow Per Share | - | 0.24 | 0.28 | 0.27 | 0.19 | 0.02 | Upgrade
|
| Gross Margin | 59.92% | 70.24% | 70.28% | 74.28% | 67.57% | 44.19% | Upgrade
|
| Operating Margin | 40.33% | 52.76% | 51.56% | 57.07% | 49.41% | 7.70% | Upgrade
|
| Profit Margin | 16.73% | 37.20% | 35.02% | 36.63% | 33.91% | 82.00% | Upgrade
|
| Free Cash Flow Margin | - | 44.35% | 53.02% | 51.09% | 36.30% | 8.30% | Upgrade
|
| EBITDA | 2.1 | 2.9 | 2.83 | 3.11 | 2.69 | 0.22 | Upgrade
|
| EBITDA Margin | 41.25% | 53.63% | 52.43% | 57.57% | 49.76% | 8.07% | Upgrade
|
| D&A For EBITDA | 0.05 | 0.05 | 0.05 | 0.03 | 0.02 | 0.01 | Upgrade
|
| EBIT | 2.06 | 2.85 | 2.78 | 3.08 | 2.67 | 0.21 | Upgrade
|
| EBIT Margin | 40.33% | 52.76% | 51.56% | 57.07% | 49.41% | 7.70% | Upgrade
|
| Effective Tax Rate | 55.32% | 25.59% | 25.20% | 25.22% | 13.02% | - | Upgrade
|
| Revenue as Reported | 5.14 | 5.42 | 5.44 | 5.43 | 5.4 | 2.7 | Upgrade
|
| Advertising Expenses | - | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.